2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance.
Cuchel M, Raal FJ, Hegele RA, Al-Rasadi K, Arca M, Averna M, Bruckert E, Freiberger T, Gaudet D, Harada-Shiba M, Hudgins LC, Kayikcioglu M, Masana L, Parhofer KG, Roeters van Lennep JE, Santos RD, Stroes ESG, Watts GF, Wiegman A, Stock JK, Tokgözoğlu LS, Catapano AL, Ray KK.
Eur Heart J. 2023 Jul 1;44(25):2277-2291. doi: 10.1093/eurheartj/ehad197.
Apheresis: What Should a Clinician Know?
Parhofer KG.
Curr Atheroscler Rep. 2023 Mar;25(3):77-83. doi: 10.1007/s11883-023-01081-7. Epub 2023 Jan 26.
Current Role of Lipoprotein Apheresis.
Thompson G, Parhofer KG.
Curr Atheroscler Rep. 2019 May 1;21(7):26. doi: 10.1007/s11883-019-0787-5.
[Update lipidology : Evidence-based treatment of dyslipidemia].
Parhofer KG.
Inn Med (Heidelb). 2023 Jul;64(7):611-621. doi: 10.1007/s00108-023-01536-8. Epub 2023 Jun 15.
FAMILIAL COMBINED HYPERLIPIDEMIA: CURRENT KNOWLEDGE, PERSPECTIVES, AND CONTROVERSIES.
Bello-Chavolla OY, Kuri-García A, Ríos-Ríos M, Vargas-Vázquez A, Cortés-Arroyo JE, Tapia-González G, Cruz-Bautista I, Aguilar-Salinas CA.
Rev Invest Clin. 2018;70(5):224-236. doi: 10.24875/RIC.18002575.
Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian Society for the Study of Atherosclerosis (SISA).
Tarugi P, Bertolini S, Calandra S, Arca M, Angelico F, Casula M, Cefalù AB, D'Erasmo L, Fortunato G, Perrone-Filardi P, Rubba P, Suppressa P, Averna M, Catapano AL.
Nutr Metab Cardiovasc Dis. 2024 Aug;34(8):1819-1836. doi: 10.1016/j.numecd.2024.05.002. Epub 2024 May 7.
Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study.
Pérez de Isla L, Díaz-Díaz JL, Romero MJ, Muñiz-Grijalvo O, Mediavilla JD, Argüeso R, Sánchez Muñoz-Torrero JF, Rubio P, Álvarez-Baños P, Ponte P, Mañas D, Suárez Gutierrez L, Cepeda JM, Casañas M, Fuentes F, Guijarro C, Ángel Barba M, Saltijeral Cerezo A, Padró T, Mata P; SAFEHEART Study Group.
Circulation. 2023 May 9;147(19):1436-1443. doi: 10.1161/CIRCULATIONAHA.122.062557. Epub 2023 Apr 3.
Lipoprotein(a) as Part of the Diagnosis of Clinical Familial Hypercholesterolemia.
Langsted A, Nordestgaard BG.
Curr Atheroscler Rep. 2022 Apr;24(4):289-296. doi: 10.1007/s11883-022-01002-0. Epub 2022 Feb 2.
Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular Outcomes.
D'Erasmo L, Minicocci I, Nicolucci A, Pintus P, Roeters Van Lennep JE, Masana L, Mata P, Sánchez-Hernández RM, Prieto-Matos P, Real JT, Ascaso JF, Lafuente EE, Pocovi M, Fuentes FJ, Muntoni S, Bertolini S, Sirtori C, Calabresi L, Pavanello C, Averna M, Cefalu AB, Noto D, Pacifico AA, Pes GM, Harada-Shiba M, Manzato E, Zambon S, Zambon A, Vogt A, Scardapane M, Sjouke B, Fellin R, Arca M.
J Am Coll Cardiol. 2018 Jan 23;71(3):279-288. doi: 10.1016/j.jacc.2017.11.028.
Influence of lipid metabolism disorders on venous thrombosis risk.
Spasić I, Ubavić M, Šumarac Z, Todorović M, Vučković B.
J Med Biochem. 2021 Jun 5;40(3):245-251. doi: 10.5937/jomb0-27106.
